These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2157776)

  • 41. Expression of the functional erythropoietin receptors on interleukin 3-dependent murine cell lines.
    Tsao CJ; Tojo A; Fukamachi H; Kitamura T; Saito T; Urabe A; Takaku F
    J Immunol; 1988 Jan; 140(1):89-93. PubMed ID: 2826592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Growth inhibition of erythroid colonies by autologous sera and the clinical effect of erythropoietin in chronic renal disease].
    Wang JY; Hotta T; Murate T; Inoue C; Saito H; Ikeda Y; Ogawa H; Saito A
    Rinsho Ketsueki; 1989 Jul; 30(7):975-9. PubMed ID: 2810799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythropoietin use in CKD patients with cancer: to tread with caution?
    Nayak-Rao S; McCormick B
    J Nephrol; 2013; 26(5):829-35. PubMed ID: 24052463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of daily subcutaneous administration of recombinant erythropoietin on chronic anemia in rheumatoid arthritis.
    Kato Y; Takagi C; Tanaka J; Masaki Y; Furuya H
    Intern Med; 1994 Apr; 33(4):193-7. PubMed ID: 8069012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptors for erythropoietin in mouse and human erythroid cells and placenta.
    Sawyer ST; Krantz SB; Sawada K
    Blood; 1989 Jul; 74(1):103-9. PubMed ID: 2546618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subunit structure of the erythropoietin receptor.
    McCaffery PJ; Fraser JK; Lin FK; Berridge MV
    J Biol Chem; 1989 Jun; 264(18):10507-12. PubMed ID: 2543671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of erythropoietin to receptors on fetal mouse liver cells.
    Saito T; Tojo A
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1565-77. PubMed ID: 2833845
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies.
    Means RT; Olsen NJ; Krantz SB; Dessypris EN; Graber SE; Stone WJ; O'Neil VL; Pincus T
    Arthritis Rheum; 1989 May; 32(5):638-42. PubMed ID: 2719734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses.
    Li Y; Juul SE; Morris-Wiman JA; Calhoun DA; Christensen RD
    Pediatr Res; 1996 Sep; 40(3):376-80. PubMed ID: 8865271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells.
    Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4126-30. PubMed ID: 3035570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of anemia of nephrotic syndrome with recombinant erythropoietin.
    Gansevoort RT; Vaziri ND; de Jong PE
    Am J Kidney Dis; 1996 Aug; 28(2):274-7. PubMed ID: 8768925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial purification and characterization of erythropoietin receptors from erythroid progenitor cells.
    Im JH; Lee SJ; Kim HD
    Arch Biochem Biophys; 1990 May; 278(2):486-91. PubMed ID: 2158283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythropoietin: evolving clinical applications.
    Abels RI; Rudnick SA
    Exp Hematol; 1991 Sep; 19(8):842-50. PubMed ID: 1868899
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization of erythropoietin receptor on erythropoietin-unresponsive mouse erythroleukemia cells.
    Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
    Biochim Biophys Acta; 1988 Aug; 943(2):326-30. PubMed ID: 2840960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photoaffinity labeling of the erythropoietin receptor and its identification in a ligand-free form.
    Hosoi T; Sawyer ST; Krantz SB
    Biochemistry; 1991 Jan; 30(2):329-35. PubMed ID: 1846294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD).
    Swaak AJ; Nieuwenhuizen C; Vreugdenhil G
    Clin Exp Rheumatol; 1994; 12(5):577. PubMed ID: 7842542
    [No Abstract]   [Full Text] [Related]  

  • 58. Erythropoietin: a hormone finds a purpose.
    Bargman JM
    J Rheumatol; 1991 Aug; 18(8):1121-3. PubMed ID: 1941810
    [No Abstract]   [Full Text] [Related]  

  • 59. Developmental changes in erythropoietin receptor expression of fetal mouse liver.
    Masuda S; Hisada Y; Sasaki R
    FEBS Lett; 1992 Feb; 298(2-3):169-72. PubMed ID: 1312022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the structure of the erythropoietin receptor by ligand blotting.
    Atkins HL; Broudy VC; Papayannopoulou T
    Blood; 1991 Jun; 77(12):2577-82. PubMed ID: 1646043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.